Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Naringenin Suppresses Neuroinflammatory Responses Through Inducing Suppressor of Cytokine Signaling 3 Expression.
Incidence of Multiple Sclerosis and Related Disorders in Asian Populations of British Columbia.
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Gray Matter Involvement in Radiologically Isolated Syndrome.
Novel MRI and PET markers of neuroinflammation in multiple sclerosis.
Progesterone's role in neuroprotection, a review of the evidence.
Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study.
Isolated cognitive relapses in multiple sclerosis.
Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading.
(+)-naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats.
How reliable is the classification of cognitive impairment across different criteria in early and late stages of multiple sclerosis?
An MRI review of acquired corpus callosum lesions.
Bilateral Surgical Reconstruction for Internal Jugular Veins Disease in Patients With Chronic Cerebrospinal Venous Insufficiency and associated Multiple Sclerosis.
Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis (MS-STAT)
In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response.
Sural sparing in Guillain-Barré syndrome subtypes: a reappraisal with historical and recent definitions.
Interlukin-18 Is a Pivot Regulatory Factor on Matrix Metalloproteinase-13 Expression and Brain Astrocytic Migration.
Transolfactory neuroinvasion by viruses threatens the human brain.
CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4.
Time-Lapse Imaging of Glial-Axonal Interactions.
Experimental and therapeutic opportunities for stem cells in multiple sclerosis.
Telephone-based physical activity counseling for major depression in people with multiple sclerosis.
Mechanical energy expenditure of subject with multiple sclerosis engaged in daily activities: a case study.
Cigarette smoking and associated risk of multiple sclerosis in the Iranian population.
Alpha-B-crystallin induces an immune-regulatory and antiviral microglial response in preactive multiple sclerosis lesions.
Pages
« first
‹ previous
…
417
418
419
420
421
422
423
424
425
…
next ›
last »